Kennedy Trust, Janssen, Hospira, Celltrion
- Date:
- 2012-2016
- Reference:
- SA/KET/C/2/13/2
- Part of:
- The Kennedy Trust for Rheumatology Research
- Archives and manuscripts
Collection contents
About this work
Description
Documents relating to the case between Hospira Healthcare Corporation (Plaintiff) and The Kennedy Trust for Rheumatology Research (Defendant) and between The Kennedy Trust for Rheumatology Research, Janssen Biotech and Cilag GmbH International (Plaintiffs by Counterclaim) and Hospira Healthcare Corporation, Celltrion Healthcare Co. Ltd and Celltrion Inc. (Defendants to the Counterclaim). The case related to argued patent invalidity/ patent infringement in relation to a Canadian filing of the patent "Anti-TNF Antibodies and Methotrexate in the Treatment of Autoimmune Disease". See SA/KET/A/7/5 for further documents relating to the case.
Publication/Creation
2012-2016
Physical description
3 boxes